Inhibition of ZEB1 leads to inversion of metastatic characteristics and restoration of paclitaxel sensitivity of chronic chemoresistant ovarian carcinoma cells.
about
Inhibition of ZEB1 leads to inversion of metastatic characteristics and restoration of paclitaxel sensitivity of chronic chemoresistant ovarian carcinoma cells.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh-hant
name
Inhibition of ZEB1 leads to in ...... stant ovarian carcinoma cells.
@en
Inhibition of ZEB1 leads to in ...... stant ovarian carcinoma cells.
@nl
type
label
Inhibition of ZEB1 leads to in ...... stant ovarian carcinoma cells.
@en
Inhibition of ZEB1 leads to in ...... stant ovarian carcinoma cells.
@nl
prefLabel
Inhibition of ZEB1 leads to in ...... stant ovarian carcinoma cells.
@en
Inhibition of ZEB1 leads to in ...... stant ovarian carcinoma cells.
@nl
P2093
P2860
P356
P1433
P1476
Inhibition of ZEB1 leads to in ...... stant ovarian carcinoma cells.
@en
P2093
Eiko Yamamoto
Fumi Utsumi
Fumitaka Kikkawa
Hiroaki Kajiyama
Jun Sakata
Kaoru Niimi
Kiyosumi Shibata
Shiro Suzuki
Takeshi Senga
P2860
P304
99482-99494
P356
10.18632/ONCOTARGET.20107
P407
P577
2017-08-10T00:00:00Z